| Literature DB >> 33368471 |
Emma L McConnell1,2,3, Kathryn J Saunders1, Julie-Anne Little1.
Abstract
PURPOSE: Cerebral visual impairment (CVI) is the leading cause of childhood visual impairment in the developed world. Despite this, there are no agreed clinical guidelines for the investigation and diagnosis of the condition. Before development of such guidelines can commence, it is important to recognise which approaches are currently employed. This systematic review evaluated the literature to identify which methods of assessment are currently used to investigate and diagnose childhood CVI.Entities:
Keywords: cerebral visual impairment; childhood visual impairment; children; cortical visual impairment; diagnosis; investigation
Year: 2020 PMID: 33368471 PMCID: PMC8048590 DOI: 10.1111/opo.12776
Source DB: PubMed Journal: Ophthalmic Physiol Opt ISSN: 0275-5408 Impact factor: 3.117
Figure 1Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) diagram of selection process for relevant articles in review.
Categories of assessment reported in included articles, where X = use reported by article and ‐ = use not reported by article for each assessment category
| Articles | Quality assessment | Participant details | Sample size | Medical history | Vision assessment/Ophthalmologic examination | Neuroimaging | Visual behaviour and direction observation | Structured history ‐taking | Visual perceptual tests | Ocular movements and posture | Intelligence test | Clinical electrophysiology | Neuro developmental assessment | Number of assessment methods used | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean age (years) | Age range (years) | No. of CVI | No. of controls | |||||||||||||
| Philip (2017) | A | 1478 | X | X | X | X | X | ‐ | X | X | ‐ | ‐ | 7 | |||
| Duke et al. (2019) | A | 4–16 | 370 | X | X | X | X | X | X | X | ‐ | ‐ | ‐ | 7 | ||
| Bosch et al. (2014) | A | (Mdn 3) | 309 | X | X | X | X | ‐ | ‐ | X | ‐ | X | ‐ | 6 | ||
| Andersson et al. (2006) | A | (Mdn 9.3) | 75 | 140 | X | X | X | ‐ | X | ‐ | X | X | ‐ | X | 7 | |
| Handa et al. (2018) | A | 1.53 | 0.24–6.37 | 53 | X | X | ‐ | ‐ | ‐ | ‐ | X | ‐ | X | ‐ | 4 | |
| Whiting et al. (1985) | A | 0.5–19 | 50 | X | X | X | ‐ | ‐ | ‐ | X | X | X |
‐ | 6 | ||
| Ortibus et al. (2011) | A | 6.83 | 3.42–17 | 45 | 46 | X | X | X | X | X | X | X | X | ‐ | ‐ | 8 |
| van Genderen et al. (2012) | A | 8 | 5–16 | 30 | 23 | X | X | X | ‐ | X | X | ‐ | X | ‐ | ‐ | 6 |
| Ortibus et al. (2009) | A | 0.5 | 4–20 | 29 | 70 | X | X | X | ‐ | ‐ | X | ‐ | X | ‐ | ‐ | 5 |
| Ferziger et al. (2011) | A | 8.25 | 3–20 | 26 | 51 | X | X | X | X | X | ‐ | X | ‐ | ‐ | ‐ | 6 |
| Geldof et al. (2015) | A | 5.5 | 25 | 62 | X | X | ‐ | X | X | X | X | X | ‐ | ‐ | 7 | |
|
Roman‐Lantzy (2007) | A | X | ‐ | ‐ | X | X | ‐ | ‐ | ‐ | ‐ | ‐ | 3 | ||||
| Matsuba & Jan (2006) | B | 423 | X | X | ‐ | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | 3 | |||
| Ben Itzhak et al. (2019) | B | (Mdn 6.42) | 3–20 | 179 | 166 | X | X | X | ‐ | X | ‐ | X | X | ‐ | ‐ | 6 |
| Jasper & Philip (2018) | B | 4 definite CVI group, 2 probable CVI group | 0.25–17 | 167 definite 109 probable | 65 | X | X | X | X | X | ‐ | X | ‐ | X | ‐ | 7 |
| Fazzi et al. (2007) | B | 4.5 | 0.25–15 | 121 | X | X | X | X | ‐ | X | X | X | X | X | 9 | |
| Brodsky et al. (2002) | B | 100 | X | X | X | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | 4 | |||
| Khetpal et al. (2007) | B | 3.1 | 0.2–19 | 98 | X | X | X | X | ‐ | ‐ | X | ‐ | ‐ | ‐ | 5 | |
| Mitry et al. (2016) | B | 4–15 | 90 | X | X | ‐ | ‐ | X | X | ‐ | ‐ | ‐ | ‐ | 4 | ||
| Salati et al. (2003) | B | 7.1 | 2–16 | 56 | X | X | X | X | ‐ | ‐ | X | X | X | X | 8 | |
| Kooiker et al. (2015) | B | 8.5 | 1.08–12.9 | 48 | 56 | X | X | ‐ | ‐ | ‐ | X | X | X | ‐ | ‐ | 5 |
| Macintyre‐Beon et al. (2013) | B | 5.5–12.3 | 46 | 130 | X | X | ‐ | X | X | X | X | X | ‐ | ‐ | 7 | |
| Skoczenski & Good (2004) | B | 3.5 | 0.33–16 | 35 | X | X | ‐ | ‐ | ‐ | ‐ | X | ‐ | X | ‐ | 4 | |
| Weinstein et al. (2012) | B | 6.75 | 5–16 | 19 | 81 | X | X | X | ‐ | ‐ | ‐ | X | ‐ | X | ‐ | 5 |
| Vancleef et al. (2020a) | B | 6.83 | 4–9.08 | 12 | 25 | X | X | X | ‐ | ‐ | X | ‐ | X | ‐ | ‐ | 5 |
| Salati et al. (2001) | B | 5 | 1–9 | 11 | X | X | X | X | ‐ | ‐ | X | ‐ | X | ‐ | 6 | |
| Philip et al. (2016) | C | 3.8 | 0–17 | 342 | X | X | ‐ | X | X | ‐ | X | ‐ | ‐ | ‐ | 5 | |
| Pehere et al. (2018) | C | 5.24 | 124 | X | X | ‐ | ‐ | ‐ | ‐ | X | ‐ | ‐ | X | 4 | ||
| Huo et al. (1999) | C | 3 | 170 | X | X | X | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | 4 | ||
| Hård et al. (2004) | C | (Mdn 6.7) | 91 | X | X | X | ‐ | X | X | X | ‐ | ‐ | ‐ | 6 | ||
| Dutton et al. (1996) | C | 90 | X | X | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | 3 | |||
| Salavati et al. (2015) | C | 9.5 | 4.17–12 | 77 | X | X | ‐ | X | ‐ | ‐ | ‐ | X | ‐ | ‐ | 4 | |
| Houliston et al. (1999) | C | 52 | 200 | X | X | ‐ | ‐ | X | ‐ | X | ‐ | ‐ | ‐ | 4 | ||
| Cioni et al. (1997) | C | 11.8 | 48 | 18 | X | X | X | X | ‐ | ‐ | X | ‐ | ‐ | ‐ | 5 | |
| Cioni et al. (1996) | C | (Mdn 2.21) | 48 | 32 | X | X | X | X | ‐ | ‐ | X | ‐ | X | ‐ | 6 | |
| Kooiker et al. (2014) | C | 7.3 | 1.1–12.9 | 42 | 127 | X | X | X | ‐ | ‐ | ‐ | X | X | ‐ | ‐ | 5 |
| Good (2001) | C | 0.5–16 | 41 | X | X | ‐ | X | ‐ | ‐ | ‐ | ‐ | X | ‐ | 4 | ||
| Salavati et al. (2017) | C | 9.4 | 4.5–12 | 37 | X | X | ‐ | ‐ | ‐ | ‐ | ‐ | X | ‐ | ‐ | 3 | |
| Macintyre‐Beon et al. (2012) | C | 10.8 | 5–16.5 | 36 | 156 | ‐ | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | 1 |
| Good et al. (2012) | C | 1.94 | 0.42–5 | 34 | 16 | X | X | X | ‐ | ‐ | ‐ | ‐ | ‐ | X | ‐ | 4 |
| Chen et al. (1992) | C | 30 | X | X | X | ‐ | ‐ | ‐ | X | ‐ | ‐ | X | 5 | |||
| Lanzi et al. (1998) | C | 3.5 | 1.67–5.5 | 23 | 12 | X | X | X | ‐ | ‐ | ‐ | X | ‐ | X | X | 6 |
| Franki et al. (2017) | C | 4.25 | 23 | 51 | ‐ | ‐ | X | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | 2 | |
| Weiss et al. (2001) | C | 0.51 | 0.08–1.08 | 17 | 31 | X | X | X | ‐ | ‐ | ‐ | X | ‐ | X | X | 6 |
| Eken et al. (1996) | C | 0.77–1.5 | 9 | X | X | X | X | ‐ | ‐ | X | ‐ | X | X | 7 | ||
| Suner et al. (2016) | C | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | ||||
| Total number of articles | 43 (93.5%) | 43 (93.5%) | 29 (63%) | 19 (41%) | 17 (37%) | 12 (26%) | 33 (72%) | 16 (35%) | 15 (33%) | 8 (17%) | ||||||
Quality assessment: A = Complete, B = Partial, C = Incomplete used to order articles, followed by number of participants with CVI included in article. Mdn = median.
Diagnostic tests and descriptions described by included articles, where X = use reported by article, ‐ = use not reported by article for each diagnostic category
| Article | Vision measures/ ophthalmologic exam | Neurological findings | Medical history | Structured history‐taking | Visual perception tests | Observation of characteristic behaviours associated with CVI | Intelligence (IQ) assessment | Electrophysiological results | Not clear | Number of methods used to diagnose | Number of assessment methods used (taken from Table | Assessment utility score (taken from Appendix | Quality assessment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Duke et al. (2019) | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 7 | 13 | A |
| Geldof et al. (2015) | X | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | 2 | 7 | 13 | A |
| Ortibus et al. (2011) | X | X | X | ‐ | X | ‐ | ‐ | ‐ | ‐ | 4 | 8 | 13 | A |
| Andersson et al. (2006) | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 7 | 11 | A |
| Philip (2017) | X | X | X | X | ‐ | X | X | ‐ | ‐ | 6 | 7 | 10 | A |
| van Genderen et al. (2012) | X | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 2 | 6 | 10 | A |
| Bosch et al. (2014) | X | ‐ | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | 2 | 6 | 10 | A |
| Ortibus et al. (2009) | ‐ | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | 1 | 5 | 9 | A |
| Ferziger et al. (2011) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 6 | 9 | A |
| Whiting et al. (1985) | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | X | ‐ | 1 | 6 | 8 | A |
| Handa et al. (2018) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 4 | 7 | A |
| Roman‐Lantzy (2007) | ‐ | ‐ | ‐ | X | ‐ | X | ‐ | ‐ | ‐ | 2 | 3 | 5 | A |
| Fazzi et al. (2007) | X | X | ‐ | ‐ | ‐ | ‐ | ‐ | X | ‐ | 3 | 9 | 17 | B |
| Salati et al. (2003) | X | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 2 | 8 | 15 | B |
| Macintyre‐Beon et al. (2013) | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 7 | 11 | B |
| Jasper & Philip (2018) | X | ‐ | X | X | ‐ | ‐ | ‐ | ‐ | ‐ | 3 | 7 | 11 | B |
| Salati et al. (2001) | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 6 | 10 | B |
| Ben Itzhak et al. (2019) | ‐ | X | X | ‐ | X | ‐ | X | ‐ | ‐ | 4 | 6 | 9 | B |
| Weinstein et al. (2012) | X | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 2 | 5 | 8 | B |
| Vancleef et al. (2020) | X | X | ‐ | ‐ | X | ‐ | X | ‐ | ‐ | 4 | 5 | 7 | B |
| Kooiker et al. (2015) | ‐ | ‐ | X | ‐ | ‐ | ‐ | X | ‐ | ‐ | 2 | 5 | 7 | B |
| Khetpal et al. (2007) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 5 | 6 | B |
| Skoczenski & Good (2004) | X | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 2 | 4 | 6 | B |
| Mitry et al. (2016) | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 4 | 6 | B |
| Brodsky et al. (2002) | X | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 2 | 4 | 6 | B |
| Matsuba & Jan (2006) | X | X | X | ‐ | ‐ | X | ‐ | X | ‐ | 5 | 3 | 5 | B |
| Eken et al. (1996) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 7 | 14 | C |
| Hård et al. (2004) | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | X | 6 | 10 | C | |
| Lanzi et al. (1998) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 5 | 11 | C |
| Weiss et al. (2001) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 6 | 8 | C |
| Philip et al. (2016) | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | X | 5 | 7 | C | |
| Pehere et al. (2018) | X | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 2 | 4 | 7 | C |
| Good (2001) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 4 | 7 | C |
| Houliston et al. (1999) | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 4 | 6 | C |
| Cioni et al. (1996) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 6 | 6 | C |
| Good et al. (2012) | X | X | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 3 | 4 | 6 | C |
| Chen et al. (1992) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 5 | 6 | C |
| Cioni et al. (1997) | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | X | 5 | 6 | C | |
| Huo et al. (1999) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 4 | 6 | C |
| Kooiker et al. (2014) | ‐ | ‐ | X | ‐ | ‐ | ‐ | X | ‐ | ‐ | 2 | 5 | 6 | C |
| Dutton et al. (1996) | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | X | 3 | 5 | C | |
| Salavati et al. (2015) | X | ‐ | X | ‐ | ‐ | X | ‐ | ‐ | ‐ | 3 | 3 | 5 | C |
| Salavati et al. (2017) | X | X | X | ‐ | ‐ | X | ‐ | ‐ | ‐ | 3 | 3 | 4 | C |
| Franki et al. (2017) | ‐ | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | 1 | 2 | 3 | C |
| Macintyre‐Beon et al. (2012) | ‐ | ‐ | ‐ | X | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 1 | 2 | C |
| Suner et al. (2016) | X | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 1 | 1 | 1 | C |
| Total number of articles using diagnostic method | 28 | 13 | 12 | 9 | 6 | 6 | 5 | 3 | 4 |
Quality assessment: A = Complete, B = Partial, C = Incomplete.